What is Narcan®/Naloxone?

Narcan, also known as Naloxone, is a nasal spray used for the treatment of a known or suspected opioid overdose emergency.

How Do You Use Narcan®/Naloxone?

Signs of an Opioid Overdose:

  • ​Unconsciousness, inability to wake up, or limp body
  • Extreme drowsiness or falling asleep
  • Slow, shallow, irregular or no breathing
  • Pale, blue, cold and/or clammy skin
  • Slow or no heartbeat
  • Fingernails or lips are purple/blue​
  • ​Vomiting or gurgling noises

Where Can You Get Narcan®?

Naloxone365 Program
No ID or insurance required, but you must be over the age of 14.
Search for participating pharmacies here:
https://data.nj.gov/Human-Services/Naloxone365-NJ-Free-Naloxone-at-Pharmacies-Program/nfsa-3664/data​
Atlantic County Department of Human Services, Division of Public Health, Substance Abuse Services​​
​https://www.atlantic-county.org/public-health/narcan-training.asp
(609) 645-5932 Option 3
NEXT Distro
 https://nextdistro.org/njgate
After watching a video on the proper use of NARCAN, you will be able to place an order online. 
Oasis Drop In Center
​32 South Tennessee Avenue, Atlantic City, NJ 08401  
Open Monday-Friday: 9AM-12:30PM & 1:30PM-3PM
By Appointment and Walk-In, (609) 572-1929
Urban Treatment Associates
​​Virtual Trainings: Wednesdays at 5PM and Thursdays at 11AM
To enroll email [email protected] or call (856) 225-0505

Naloxone365 Pilot Program


New Jersey now has a pilot program that ​allows pharmacies to dispense opioid antidotes, at no cost, to anonymous recipients at any time. 
​
More Information:
There is no cost
You do not need a prescription
You do not need a name or reason
You MUST be age 14 or older
There is a limit of one kit (contains 2 doses) per visit


For more information on the pilot program please contact:
The New Jersey Department of Human Services
Email: [email protected]
Phone: 1 (609) 438-4352
This website was developed in part under grant number SP019814-01 from the Office of National Drug Control Policy and Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services.  The views, policies and opinions expressed are those of the authors and do not necessarily reflect those of ONDCP, SAMHSA or HHS.
Contact [email protected] for more information.